|
Ed Marlowe is President and CEO and co-founder of NFG Stuff, LLC, a company created to develop, manufacture and market hair care products to teen boys and young men. He recently retired as the Chairman of the Paper Mill Playhouse in Millburn, NJ, one of the largest regional theaters in the country.
In June 2000, Ed Marlowe retired from Bristol-Myers Squibb Beauty Care Division as Senior Vice President of Research and Development. There, he was responsible for all scientific and technical operations for the Clairol, Clairol Professional, Clairol International, Matrix, and Redmond divisions and companies. Dr. Marlowe joined the management team in 1992 when the company was a $300M division. The products developed under his supervision propelled the division to grow to over $3B by June 2000. Among Dr. Marlowe's accomplishments was the development of the Herbal Essence product line, Amplify. He also led the establishment of new safety standards for hair coloring products that have been adopted throughout the world.
Prior to joining Clairol, Dr. Marlowe was Corporate VP and President Consumer Products Research and Development Division for Warner Lambert where he was responsible for the worldwide research and development activities from 1981-1991. Dr. Marlowe had a string of consumer product successes including the anti-plaque, anti-gingivitis claims for Listerine including the seal of approval of the American Dental Association, creating a "good tasting" Cool Mint Listerine and the Rx to OTC switch of Benadryl.
From 1972 to 1981, Dr. Marlowe was VP R&D for the Consumer Health Products Division of Schering-Plough. Prior to this Dr. Marlowe held various positions at Whitehall Labs, Ortho Pharmaceuticals, and Merck. He was responsible for the development of the Sun Protection Factor (SPF) system and testing methods that were adopted by the FDA as well as the formulation of the first SPF-15 Sunblock product (Super Shade by Coppertone).
Ed received his B.S. and M.S. in Pharmaceutical Chemistry from Columbia University and his Ph.D. in Pharmaceutical Chemistry and Pharmacology from the University of Maryland. | 